{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:45:08Z","timestamp":1792424708966,"version":"4.5.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,7,23]],"date-time":"2013-07-23T00:00:00Z","timestamp":1374537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1038\/nrneph.2013.147","type":"journal-article","created":{"date-parts":[[2013,7,23]],"date-time":"2013-07-23T13:45:21Z","timestamp":1374587121000},"page":"641-649","source":"Crossref","is-referenced-by-count":111,"title":["FGF-23 and secondary hyperparathyroidism in chronic kidney disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Justin","family":"Silver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tally","family":"Naveh-Many","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,23]]},"reference":[{"key":"BFnrneph2013147_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/jbmr.5650040407","volume":"4","author":"RA Meyer","year":"1989","unstructured":"Meyer, R. A., Meyer, M. H. & Gray, R. W. Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice. J. Bone Miner. Res. 4, 493\u2013500 (1989).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph2013147_CR2","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1172\/JCI115735","volume":"89","author":"T Nesbitt","year":"1992","unstructured":"Nesbitt, T., Coffman, T. M., Griffiths, R. & Drezner, M. K. Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic defect. J. Clin. Invest. 89, 1453\u20131459 (1992).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013147_CR3","doi-asserted-by":"crossref","unstructured":"ADHR consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 26, 345\u2013348 (2000).","DOI":"10.1038\/81664"},{"key":"BFnrneph2013147_CR4","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada, T.  et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc. Natl Acad. Sci. USA 98, 6500\u20136505 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2013147_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o, M.  et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45\u201351 (1997).","journal-title":"Nature"},{"key":"BFnrneph2013147_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1073\/pnas.0902006107","volume":"107","author":"R Goetz","year":"2010","unstructured":"Goetz, R.  et al. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc. Natl Acad. Sci. USA 107, 407\u2013412 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2013147_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez, O. M.  et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N. Engl. J. Med. 359, 584\u2013592 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2013147_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1681\/ASN.2008060609","volume":"20","author":"T Isakova","year":"2009","unstructured":"Isakova, T.  et al. Phosphorus binders and survival on hemodialysis. J. Am. Soc. Nephrol. 20, 388\u2013396 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013147_CR9","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/ndt\/gfp699","volume":"25","author":"JH Ix","year":"2009","unstructured":"Ix, J. H., Shlipak, M. G., Wassel, C. L. & Whooley, M. A. Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study. Nephrol. Dial. Transplant. 25, 993\u2013997 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2013147_CR10","doi-asserted-by":"publisher","first-page":"F367","DOI":"10.1152\/ajprenal.00061.2002","volume":"283","author":"J Silver","year":"2002","unstructured":"Silver, J., Kilav, R. & Naveh-Many, T. Mechanisms of secondary hyperparathyroidism. Am. J. Physiol. Renal Physiol. 283, F367\u2013F376 (2002).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2013147_CR11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrneph.2012.116","volume":"8","author":"H Komaba","year":"2012","unstructured":"Komaba, H. & Fukagawa, M. The role of FGF23 in CKD\u2014with or without Klotho. Nat. Reviews Nephrol. 8, 484\u2013490 (2012).","journal-title":"Nat. Reviews Nephrol."},{"key":"BFnrneph2013147_CR12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/ki.2012.176","volume":"82","author":"M Wolf","year":"2012","unstructured":"Wolf, M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int. 82, 737\u2013747 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph2013147_CR13","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.yexcr.2012.02.027","volume":"318","author":"LD Quarles","year":"2012","unstructured":"Quarles, L. D. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. Exp. Cell Res. 318, 1040\u20131048 (2012).","journal-title":"Exp. Cell Res."},{"key":"BFnrneph2013147_CR14","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/ndt\/gfs050","volume":"27","author":"J Silver","year":"2012","unstructured":"Silver, J., Rodriguez, M. & Slatopolsky, E. FGF23 and PTH: double agents at the heart of CKD. Nephrol. Dial. Transplant. 27, 1715\u20131720 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2013147_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","volume":"61","author":"C Bergwitz","year":"2010","unstructured":"Bergwitz, C. & Juppner, H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu. Rev. Med. 61, 91\u2013104 (2010).","journal-title":"Annu. Rev. Med."},{"key":"BFnrneph2013147_CR16","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1172\/JCI106517","volume":"50","author":"E Slatopolsky","year":"1971","unstructured":"Slatopolsky, E.  et al. On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J. Clin. Invest. 50, 492\u2013499 (1971).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013147_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/ki.1973.92","volume":"4","author":"E Slatopolsky","year":"1973","unstructured":"Slatopolsky, E. & Bricker, N. S. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int. 4, 141\u2013145 (1973).","journal-title":"Kidney Int."},{"key":"BFnrneph2013147_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1172\/JCI118038","volume":"96","author":"R Kilav","year":"1995","unstructured":"Kilav, R., Silver, J. & Naveh-Many, T. Parathyroid hormone gene expression in hypophosphatemic rats. J. Clin. Invest. 96, 327\u2013333 (1995).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013147_CR19","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/jbmr.5650110714","volume":"11","author":"Y Almaden","year":"1996","unstructured":"Almaden, Y.  et al. Direct effect of phosphorus on parathyroid hormone secretion from whole rat parathyroid glands in vitro. J. Bone Miner. Res. 11, 970\u2013976 (1996).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph2013147_CR20","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1172\/JCI118701","volume":"97","author":"E Slatopolsky","year":"1996","unstructured":"Slatopolsky, E.  et al. Phosphate restriction prevents parathyroid cell growth in uremic rats. High phosphate directly stimulates PTH secretion in vitro. J. Clin. Invest. 97, 2534\u20132540 (1996).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013147_CR21","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/ndt\/11.9.1762","volume":"11","author":"PK Nielsen","year":"1996","unstructured":"Nielsen, P. K., Feldt-Rasmusen, U. & Olgaard, K. A direct effect of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells. Nephrol. Dial. Transplant. 11, 1762\u20131768 (1996).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2013147_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1138\/20110516","volume":"8","author":"R Sapir-Koren","year":"2011","unstructured":"Sapir-Koren, R. & Livshits, G. Bone mineralization and regulation of phosphate homeostasis. IBMS BoneKEy 8, 286\u2013300 (2011).","journal-title":"IBMS BoneKEy"},{"key":"BFnrneph2013147_CR23","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/ki.2010.390","volume":"79","author":"AP Sage","year":"2011","unstructured":"Sage, A. P., Lu, J. X., Tintut, Y. & Demer, L. L. Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int. 79, 414\u2013422 (2011).","journal-title":"Kidney Int."},{"key":"BFnrneph2013147_CR24","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.1210\/en.2005-0777","volume":"146","author":"F Perwad","year":"2005","unstructured":"Perwad, F.  et al. Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology 146, 5358\u20135364 (2005).","journal-title":"Endocrinology"},{"key":"BFnrneph2013147_CR25","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/ki.2010.313","volume":"78","author":"H Hasegawa","year":"2010","unstructured":"Hasegawa, H.  et al. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int. 78, 975\u2013980 (2010).","journal-title":"Kidney Int."},{"key":"BFnrneph2013147_CR26","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1172\/JCI61405","volume":"122","author":"V Shalhoub","year":"2012","unstructured":"Shalhoub, V.  et al. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J. Clin. Invest. 122, 2543\u20132553 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013147_CR27","doi-asserted-by":"publisher","first-page":"F1192","DOI":"10.1152\/ajprenal.00360.2009","volume":"297","author":"T Meir","year":"2009","unstructured":"Meir, T.  et al. Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the VDR in parathyroid physiology. Am. J. Physiol. Renal Physiol. 297, F1192\u2013F1198 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2013147_CR28","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1210\/endo.139.10.6262","volume":"139","author":"YC Li","year":"1998","unstructured":"Li, Y. C.  et al. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139, 4391\u20134396 (1998).","journal-title":"Endocrinology"},{"key":"BFnrneph2013147_CR29","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1038\/sj.ki.5002000","volume":"70","author":"Y Nishida","year":"2006","unstructured":"Nishida, Y.  et al. Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int. 70, 2141\u20132147 (2006).","journal-title":"Kidney Int."},{"key":"BFnrneph2013147_CR30","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1210\/jc.2004-1039","volume":"90","author":"SL Ferrari","year":"2005","unstructured":"Ferrari, S. L., Bonjour, J. P. & Rizzoli, R. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J. Clin. Endocrinol. Metab. 90, 1519\u20131524 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneph2013147_CR31","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.2215\/CJN.02740311","volume":"6","author":"OM Gutierrez","year":"2011","unstructured":"Gutierrez, O. M., Wolf, M. & Taylor, E. N. Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the Health Professionals Follow-up Study. Clin. J. Am. Soc. Nephrol. 6, 2871\u20132878 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2013147_CR32","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1093\/ndt\/gfm347","volume":"22","author":"PA Westerberg","year":"2007","unstructured":"Westerberg, P. A.  et al. Regulation of fibroblast growth factor-23 in chronic kidney disease. Nephrol. Dial. Transplant. 22, 3202\u20133207 (2007).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2013147_CR33","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova, T.  et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 79, 1370\u20131378 (2011).","journal-title":"Kidney Int."},{"key":"BFnrneph2013147_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00774-007-0779-3","volume":"25","author":"N Ito","year":"2007","unstructured":"Ito, N.  et al. Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans. J. Bone Miner. Metab. 25, 419\u2013422 (2007).","journal-title":"J. Bone Miner. Metab."},{"key":"BFnrneph2013147_CR35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1681\/ASN.2007060673","volume":"19","author":"T Isakova","year":"2008","unstructured":"Isakova, T.  et al. Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J. Am. Soc. Nephrol. 19, 615\u2013623 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013147_CR36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/ndt\/gfs460","volume":"28","author":"I Pavik","year":"2013","unstructured":"Pavik, I.  et al. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol. Dial. Transplant. 28, 352\u2013359 (2013).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2013147_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin, A.  et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 71, 31\u201338 (2007).","journal-title":"Kidney Int."},{"key":"BFnrneph2013147_CR38","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2215\/CJN.05420709","volume":"5","author":"RB Oliveira","year":"2010","unstructured":"Oliveira, R. B.  et al. Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clin. J. Am. Soc. Nephrol. 5, 286\u2013291 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2013147_CR39","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/ndt\/gfq419","volume":"26","author":"T Isakova","year":"2011","unstructured":"Isakova, T.  et al. Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol. Dial. Transplant. 26, 584\u2013591 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2013147_CR40","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1093\/ndt\/gfr144","volume":"26","author":"E Gonzalez-Parra","year":"2011","unstructured":"Gonzalez-Parra, E.  et al. Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients. Nephrol. Dial. Transplant. 26, 2567\u20132571 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2013147_CR41","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1210\/jc.2004-0724","volume":"89","author":"A Gupta","year":"2004","unstructured":"Gupta, A., Winer, K., Econs, M. J., Marx, S. J. & Collins, M. T. FGF-23 is elevated by chronic hyperphosphatemia. J. Clin. Endocrinol. Metab. 89, 4489\u20134492 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneph2013147_CR42","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1507\/endocrj.K06-156","volume":"54","author":"H Yamashita","year":"2007","unstructured":"Yamashita, H.  et al. Fibroblast growth factor-23 (FGF23) in patients with transient hypoparathyroidism: its important role in serum phosphate regulation. Endocr. J. 54, 465\u2013470 (2007).","journal-title":"Endocr. J."},{"key":"BFnrneph2013147_CR43","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1210\/jc.2005-0301","volume":"90","author":"K Araya","year":"2005","unstructured":"Araya, K.  et al. A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. J. Clin. Endocrinol. Metab. 90, 5523\u20135527 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneph2013147_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/eje.0.1510055","volume":"151","author":"H Yamashita","year":"2004","unstructured":"Yamashita, H.  et al. Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism. Eur. J. Endocrinol. 151, 55\u201360 (2004).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrneph2013147_CR45","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.4065\/79.12.1508","volume":"79","author":"PJ Tebben","year":"2004","unstructured":"Tebben, P. J., Singh, R. J., Clarke, B. L. & Kumar, R. Fibroblast growth factor 23, parathyroid hormone, and 1\u03b1,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism. Mayo Clin. Proc. 79, 1508\u20131513 (2004).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrneph2013147_CR46","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/jbmr.433","volume":"26","author":"Q Yuan","year":"2011","unstructured":"Yuan, Q.  et al. FGF-23\/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH. J. Bone Miner. Res. 26, 2026\u20132035 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph2013147_CR47","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1681\/ASN.2004080694","volume":"16","author":"KA Lomashvili","year":"2005","unstructured":"Lomashvili, K. A., Khawandi, W. & O'Neill, W. C. Reduced plasma pyrophosphate levels in hemodialysis patients. J. Am. Soc. Nephrol. 16, 2495\u20132500 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013147_CR48","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1172\/JCI108327","volume":"57","author":"AC Alfrey","year":"1976","unstructured":"Alfrey, A. C. & Solomons, C. C. Bone pyrophosphate in uremia and its association with extraosseous calcification. J. Clin. Invest. 57, 700\u2013705 (1976).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013147_CR49","doi-asserted-by":"publisher","first-page":"21372","DOI":"10.1073\/pnas.1214231110","volume":"109","author":"LFA Huitema","year":"2012","unstructured":"Huitema, L. F. A.  et al. Entpd5 is essential for skeletal mineralization and regulates phosphate homeostasis in zebrafish. Proc. Natl Acad. Sci. USA 109, 21372\u201321377 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2013147_CR50","doi-asserted-by":"crossref","unstructured":"Mackenzie, N. C. W.  et al. Altered bone development and an increase in FGF-23 expression in Enpp1\u2212\/\u2212 mice. PLoS ONE 7, (2012).","DOI":"10.1371\/annotation\/8f71d7e8-d81d-4878-bf14-79a313a7810b"},{"key":"BFnrneph2013147_CR51","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ajhg.2010.01.006","volume":"86","author":"B Lorenz-Depiereux","year":"2010","unstructured":"Lorenz-Depiereux, B., Schnabel, D., Tiosano, D., H\u00e4usler, G. & Strom, T. M. Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am. J. Hum. Genet. 86, 267\u2013272 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph2013147_CR52","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1101\/gad.1276205","volume":"19","author":"M Murshed","year":"2005","unstructured":"Murshed, M., Harmey, D., Millan, J. L., McKee, M. D. & Karsenty, G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev. 19, 1093\u20131104 (2005).","journal-title":"Genes Dev."},{"key":"BFnrneph2013147_CR53","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1172\/JCI36479","volume":"118","author":"LD Quarles","year":"2008","unstructured":"Quarles, L. D. Endocrine functions of bone in mineral metabolism regulation. J. Clin. Invest. 118, 3820\u20133828 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013147_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1615\/CritRevEukarGeneExpr.v22.i1.50","volume":"22","author":"PSN Rowe","year":"2012","unstructured":"Rowe, P. S. N. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway. Crit. Rev. Eukaryot. Gene Expr. 22, 61\u201386 (2012).","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"BFnrneph2013147_CR55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1152\/physrev.00002.2011","volume":"92","author":"A Martin","year":"2012","unstructured":"Martin, A., David, V. & Quarles, L. D. Regulation and function of the Fgf23\/Klotho endocrine pathways. Physiol. Rev. 92, 131\u2013155 (2012).","journal-title":"Physiol. Rev."},{"key":"BFnrneph2013147_CR56","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1096\/fj.10-177816","volume":"25","author":"A Martin","year":"2011","unstructured":"Martin, A.  et al. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling. FASEB J. 25, 2551\u20132562 (2011).","journal-title":"FASEB J."},{"key":"BFnrneph2013147_CR57","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1002\/jbmr.478","volume":"26","author":"S Wohrle","year":"2011","unstructured":"Wohrle, S.  et al. FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone. J. Bone Miner. Metab. 26, 2486\u20132497 (2011).","journal-title":"J. Bone Miner. Metab."},{"key":"BFnrneph2013147_CR58","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.cmet.2007.05.008","volume":"5","author":"LF Bonewald","year":"2007","unstructured":"Bonewald, L. F. Osteocyte messages from a bony tomb. Cell Metab. 5, 410\u2013411 (2007).","journal-title":"Cell Metab."},{"key":"BFnrneph2013147_CR59","doi-asserted-by":"crossref","unstructured":"The Hyp consortium. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat. Genet. 11, 130\u2013136 (1995).","DOI":"10.1038\/ng1095-130"},{"key":"BFnrneph2013147_CR60","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/ng1868","volume":"38","author":"B Lorenz-Depiereux","year":"2006","unstructured":"Lorenz-Depiereux, B.  et al. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat. Genet. 38, 1248\u20131250 (2006).","journal-title":"Nat. Genet."},{"key":"BFnrneph2013147_CR61","first-page":"722","volume":"118","author":"B Yuan","year":"2008","unstructured":"Yuan, B.  et al. Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia. J. Clin. Invest. 118, 722\u2013734 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013147_CR62","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1086\/427956","volume":"76","author":"KE White","year":"2005","unstructured":"White, K. E.  et al. Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am. J. Hum. Genet. 76, 361\u2013367 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph2013147_CR63","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/jor.20857","volume":"27","author":"S Goebel","year":"2009","unstructured":"Goebel, S.  et al. FGF23 is a putative marker for bone healing and regeneration. J. Orthop. Res. 27, 1141\u20131146 (2009).","journal-title":"J. Orthop. Res."},{"key":"BFnrneph2013147_CR64","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada, T.  et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 19, 429\u2013435 (2004).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph2013147_CR65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","volume":"195","author":"T Krajisnik","year":"2007","unstructured":"Krajisnik, T.  et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1\u03b1-hydroxylase expression in cultured bovine parathyroid cells. J. Endocrinol. 195, 125\u2013131 (2007).","journal-title":"J. Endocrinol."},{"key":"BFnrneph2013147_CR66","first-page":"4003","volume":"117","author":"IZ Ben Dov","year":"2007","unstructured":"Ben Dov, I. Z.  et al. The parathyroid is a target organ for FGF23 in rats. J. Clin. Invest. 117, 4003\u20134008 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013147_CR67","doi-asserted-by":"publisher","first-page":"F713","DOI":"10.1152\/ajprenal.00161.2009","volume":"297","author":"V Lavi-Moshayoff","year":"2009","unstructured":"Lavi-Moshayoff, V., Silver, J. & Naveh-Many, T. Human PTH gene regulation in vivo using transgenic mice. Am. J. Physiol. Renal Physiol. 297, F713\u2013F719 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2013147_CR68","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/ki.2009.464","volume":"77","author":"H Galitzer","year":"2010","unstructured":"Galitzer, H., Ben Dov, I. Z., Silver, J. & Naveh-Many, T. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int. 77, 211\u2013218 (2010).","journal-title":"Kidney Int."},{"key":"BFnrneph2013147_CR69","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/ki.2009.414","volume":"77","author":"H Komaba","year":"2010","unstructured":"Komaba, H.  et al. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int. 77, 232\u2013238 (2010).","journal-title":"Kidney Int."},{"key":"BFnrneph2013147_CR70","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1681\/ASN.2009040427","volume":"21","author":"R Canalejo","year":"2010","unstructured":"Canalejo, R.  et al. FGF23 fails to inhibit uremic parathyroid glands. J. Am. Soc. Nephrol. 21, 1125\u20131135 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013147_CR71","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/ki.2009.466","volume":"77","author":"H Komaba","year":"2010","unstructured":"Komaba, H. & Fukagawa, M. FGF23-parathyroid interaction: implications in chronic kidney disease. Kidney Int. 77, 292\u2013298 (2010).","journal-title":"Kidney Int."},{"key":"BFnrneph2013147_CR72","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/ki.2010.215","volume":"78","author":"J Hofman-Bang","year":"2010","unstructured":"Hofman-Bang, J., Martuseviciene, G., Santini, M. A., Olgaard, K. & Lewin, E. Increased parathyroid expression of klotho in uremic rats. Kidney Int. 78, 1119\u20131127 (2010).","journal-title":"Kidney Int."},{"key":"BFnrneph2013147_CR73","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1530\/eje.1.02053","volume":"154","author":"K Kobayashi","year":"2006","unstructured":"Kobayashi, K.  et al. Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. Eur. J. Endocrinol. 154, 93\u201399 (2006).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrneph2013147_CR74","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1210\/jc.2008-0220","volume":"94","author":"WW Brown","year":"2008","unstructured":"Brown, W. W.  et al. Hypophosphatemia with elevations in serum FGF23 in a child with Jansen's metaphyseal chondrodysplasia in Jansen's syndrome. J. Clin. Endocrinol. Metab. 94, 17\u201320 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneph2013147_CR75","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.bone.2011.06.025","volume":"49","author":"Y Rhee","year":"2011","unstructured":"Rhee, Y.  et al. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone 49, 636\u2013643 (2011).","journal-title":"Bone"},{"key":"BFnrneph2013147_CR76","doi-asserted-by":"publisher","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","volume":"299","author":"V Lavi-Moshayoff","year":"2010","unstructured":"Lavi-Moshayoff, V., Wasserman, G., Meir, T., Silver, J. & Naveh-Many, T. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am. J. Physiol. Renal Physiol. 299, F882\u2013F889 (2010).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2013147_CR77","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/ndt\/gfr384","volume":"27","author":"M Koizumi","year":"2011","unstructured":"Koizumi, M., Komaba, H., Nakanishi, S., Fujimori, A. & Fukagawa, M. Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism. Nephrol. Dial. Transplant. 27, 784\u2013790 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2013147_CR78","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2215\/CJN.03630509","volume":"5","author":"JB Wetmore","year":"2010","unstructured":"Wetmore, J. B., Liu, S., Krebill, R., Menard, R. & Quarles, L. D. Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD. Clin. J. Am. Soc. Nephrol. 5, 110\u2013116 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2013147_CR79","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1681\/ASN.2005111185","volume":"17","author":"S Liu","year":"2006","unstructured":"Liu, S.  et al. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J. Am. Soc. Nephrol. 17, 1305\u20131315 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013147_CR80","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1074\/jbc.M408903200","volume":"280","author":"H Saito","year":"2005","unstructured":"Saito, H.  et al. Circulating FGF-23 is regulated by 1\u03b1,25-dihydroxyvitamin D3 and phosphorus in vivo. J. Biol. Chem. 280, 2543\u20132549 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2013147_CR81","doi-asserted-by":"publisher","first-page":"G1036","DOI":"10.1152\/ajpgi.00243.2005","volume":"289","author":"OI Kolek","year":"2005","unstructured":"Kolek, O. I.  et al. 1\u03b1,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G1036\u2013G1042 (2005).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrneph2013147_CR82","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","volume":"314","author":"T Shimada","year":"2004","unstructured":"Shimada, T.  et al. FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem. Biophys. Res. Commun. 314, 409\u2013414 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneph2013147_CR83","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1093\/ndt\/gfr668","volume":"27","author":"D Hansen","year":"2012","unstructured":"Hansen, D., Rasmussen, K., Pedersen, S. M., Rasmussen, L. M. & Brandi, L. Changes in fibroblast growth factor 23 during treatment of secondary hyperparathyroidism with alfacalcidol or paricalcitol. Nephrol. Dial. Transplant. 27, 2263\u20132269 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2013147_CR84","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1210\/jc.2011-2280","volume":"97","author":"E Grethen","year":"2012","unstructured":"Grethen, E.  et al. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. J. Clin. Endocrinol. Metab. 97, 1655\u20131662 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneph2013147_CR85","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/jbmr.65","volume":"25","author":"K Tsuji","year":"2010","unstructured":"Tsuji, K., Maeda, T., Kawane, T., Matsunuma, A. & Horiuchi, N. Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1\u03b1,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice. J. Bone Miner. Res. 25, 1711\u20131723 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph2013147_CR86","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00223-012-9683-5","volume":"92","author":"RK Saini","year":"2013","unstructured":"Saini, R. K.  et al. 1,25-Dihydroxyvitamin D3 regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6. Calcif. Tissue Int. 92, 339\u2013353 (2013).","journal-title":"Calcif. Tissue Int."},{"key":"BFnrneph2013147_CR87","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1172\/JCI29463","volume":"116","author":"R Masuyama","year":"2006","unstructured":"Masuyama, R.  et al. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J. Clin. Invest. 116, 3150\u20133159 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013147_CR88","doi-asserted-by":"publisher","first-page":"F1088","DOI":"10.1152\/ajprenal.00474.2004","volume":"289","author":"T Shimada","year":"2005","unstructured":"Shimada, T.  et al. Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. Am. J. Physiol. Renal Physiol. 289, F1088\u2013F1095 (2005).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2013147_CR89","doi-asserted-by":"publisher","first-page":"E724","DOI":"10.1152\/ajpendo.00557.2012","volume":"304","author":"SJ Quinn","year":"2013","unstructured":"Quinn, S. J.  et al. CaSR-mediated interactions between calcium and magnesium homeostasis in mice. Am. J. Physiol. Endocrinol. Metab. 304, E724\u2013E733 (2013).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrneph2013147_CR90","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1681\/ASN.2011101006","volume":"23","author":"ME Rodriguez-Ortiz","year":"2012","unstructured":"Rodriguez-Ortiz, M. E.  et al. Calcium deficiency reduces circulating levels of FGF23. J. Am. Soc. Nephrol. 23, 1190\u20131197 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013147_CR91","doi-asserted-by":"publisher","first-page":"19796","DOI":"10.1073\/pnas.0709805104","volume":"104","author":"CD Chen","year":"2007","unstructured":"Chen, C. D., Podvin, S., Gillespie, E., Leeman, S. E. & Abraham, C. R. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM 17. Proc. Natl Acad. Sci. USA 104, 19796\u201319801 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2013147_CR92","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1006\/bbrc.1997.8019","volume":"242","author":"Y Matsumura","year":"1998","unstructured":"Matsumura, Y.  et al. Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem. Biophys. Res. Commun. 242, 626\u2013630 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneph2013147_CR93","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1126\/science.1135901","volume":"316","author":"A Imura","year":"2007","unstructured":"Imura, A.  et al. A-Klotho as a regulator of calcium homeostasis. Science 316, 1615\u20131618 (2007).","journal-title":"Science"},{"key":"BFnrneph2013147_CR94","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1172\/JCI31330","volume":"117","author":"S Ichikawa","year":"2007","unstructured":"Ichikawa, S.  et al. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J. Clin. Invest. 117, 2684\u20132691 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013147_CR95","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1073\/pnas.0712361105","volume":"105","author":"CA Brownstein","year":"2008","unstructured":"Brownstein, C. A.  et al. A translocation causing increased \u03b1-Klotho level results in hypophosphatemic rickets and hyperparathyroidism. Proc. Natl Acad. Sci. USA 105, 3455\u20133460 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2013147_CR96","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1172\/JCI64986","volume":"122","author":"RC Smith","year":"2012","unstructured":"Smith, R. C.  et al. Circulating \u03b1Klotho influences phosphate handling by controlling FGF23 production. J. Clin. Invest. 122, 4710\u20134715 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013147_CR97","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1172\/JCI67055","volume":"122","author":"H Juppner","year":"2012","unstructured":"Juppner, H. & Wolf, M. \u03b1Klotho: FGF23 coreceptor and FGF23-regulating hormone. J. Clin. Invest. 122, 4336\u20134339 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013147_CR98","doi-asserted-by":"publisher","first-page":"F431","DOI":"10.1152\/ajprenal.00199.2012","volume":"303","author":"NS Krieger","year":"2012","unstructured":"Krieger, N. S., Culbertson, C. D., Kyker-Snowman, K. & Bushinsky, D. A. Metabolic acidosis increases fibroblast growth factor 23 in neonatal mouse bone. Am. J. Physiol. Renal Physiol. 303, F431\u2013F436 (2012).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2013147_CR99","doi-asserted-by":"publisher","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","volume":"108","author":"EG Farrow","year":"2011","unstructured":"Farrow, E. G.  et al. Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc. Natl Acad. Sci. USA 108, E1146\u2013E1155 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2013147_CR100","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1159\/000327019","volume":"33","author":"Y Takeda","year":"2011","unstructured":"Takeda, Y.  et al. Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients. Am. J. Nephrol. 33, 421\u2013426 (2011).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph2013147_CR101","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1681\/ASN.2008121258","volume":"20","author":"N Carrillo-Lopez","year":"2009","unstructured":"Carrillo-Lopez, N.  et al. Indirect regulation of PTH by estrogens may require FGF23. J. Am. Soc. Nephrol. 20, 2009\u20132017 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013147_CR102","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1093\/ndt\/gfq053","volume":"25","author":"VM Brandenburg","year":"2010","unstructured":"Brandenburg, V. M.  et al. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study. Nephrol. Dial. Transplant. 25, 2672\u20132679 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2013147_CR103","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","volume":"143","author":"T Shimada","year":"2002","unstructured":"Shimada, T.  et al. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 143, 3179\u20133182 (2002).","journal-title":"Endocrinology"},{"key":"BFnrneph2013147_CR104","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1210\/jc.2002-021105","volume":"87","author":"Y Yamazaki","year":"2002","unstructured":"Yamazaki, Y.  et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J. Clin. Endocrinol. Metab. 87, 4957\u20134960 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneph2013147_CR105","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1359\/jbmr.2001.16.5.806","volume":"16","author":"MT Collins","year":"2001","unstructured":"Collins, M. T.  et al. Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J. Bone Miner. Res. 16, 806\u2013813 (2001).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph2013147_CR106","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.bone.2005.03.002","volume":"36","author":"X Yu","year":"2005","unstructured":"Yu, X., Sabbagh, Y., Davis, S. I., Demay, M. B. & White, K. E. Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations. Bone 36, 971\u2013977 (2005).","journal-title":"Bone"},{"key":"BFnrneph2013147_CR107","doi-asserted-by":"publisher","first-page":"18370","DOI":"10.1074\/jbc.M602469200","volume":"281","author":"K Kato","year":"2006","unstructured":"Kato, K.  et al. Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J. Biol. Chem. 281, 18370\u201318377 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2013147_CR108","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.cytogfr.2005.01.002","volume":"16","author":"X Yu","year":"2005","unstructured":"Yu, X. & White, K. E. FGF23 and disorders of phosphate homeostasis. Cytokine Growth Factor Rev. 16, 221\u2013232 (2005).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnrneph2013147_CR109","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/jbmr.1546","volume":"27","author":"N Bhattacharyya","year":"2012","unstructured":"Bhattacharyya, N.  et al. Mechanism of FGF23 processing in fibrous dysplasia. J. Bone Miner. Res. 27, 1132\u20131141 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph2013147_CR110","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul, C.  et al. FGF23 induces left ventricular hypertrophy. J. Clin. Invest. 121, 4393\u20134408 (2011).","journal-title":"J. Clin. Invest."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.147","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:40:57Z","timestamp":1684471257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2013.147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,23]]},"references-count":110,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["BFnrneph2013147"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2013.147","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,23]]}}}